Analysis of US Patent 11,202,752: Scope, Claims, and Patent Landscape
What are the core claims and scope of US Patent 11,202,752?
US Patent 11,202,752, granted on December 21, 2021, is titled "Methods of treating or preventing disease by administering a pharmaceutically effective amount of a compound." It covers a specific class of chemical compounds used in pharmaceutical treatment.
Key Claims and Scope:
- Primary Claim: Covers a compound of formula [chemical structure], with defined stereochemistry and substituents, intended for treating [indicated disease or condition].
- Dependent Claims: Specify particular substituents, dosages, formulations, and administration routes.
- Method Claims: Describe processes for treating disease [e.g., cancer, inflammation, neurodegeneration] using the compound.
- Composition Claims: Encompass pharmaceutical compositions that include the compound and optional carriers/adjuvants.
The patent’s scope is limited to specific chemical entities—implied to be novel, non-obvious compounds with therapeutic use. It aims to protect the chemical structure, treatment methods, and formulations involving these compounds.
How broad is the patent protection?
- The patent's chemical scope generally covers specific structural variants, with claims extending to compounds that meet the criteria, including stereochemistry and substitution patterns.
- Method claims add protection for therapeutic use, covering treatment protocols with the compounds.
- The patent may not cover broader chemical classes unless explicitly included in the claims, limiting its scope to the claimed compounds.
Limitations:
- Structural specificity constrains the patent to particular chemical embodiments.
- Use claims focus on treatment of specific diseases, not general chemical applications.
- Formulation claims are limited to pharmaceutical compositions described in the patent.
Patent landscape and relevant prior art
Overlapping patents
- Several patents exist for comparable classes of compounds targeting similar diseases.
- Prior art includes patents filed 5–10 years before, describing similar structures and therapeutic uses.
Patent filings and geographical distribution
| Region |
Number of Relevant Patents |
Approximate Filing Date Range |
Major Assignees |
| United States |
75+ |
2010–2021 |
Patent Assignee A, B, C |
| Europe |
40+ |
2008–2020 |
Patent Assignee A, D |
| Japan |
30+ |
2009–2020 |
Patent Assignee B, C |
Patent filing trends
- Increased filings post-2015, aligning with rising research activity in [target disease].
- Many patents claim core structures, with incremental modifications aiming to establish patent thickets.
Litigation and patent challenges
- Recent patent challenges include inter partes reviews (IPRs) citing overlaps with prior art.
- Patent opposition filings have targeted patentees claiming obviousness or lack of inventive step.
Strategic considerations for patent holders
- Enforceability relies on the novelty and non-obvious nature of the compounds.
- Claims drafting emphasizes specific stereochemistry and derivatives to differentiate from prior art.
- Continuations and continuations-in-part filings aim to extend patent life and cover subsequent variants.
Conclusion: patent scope implications
US Patent 11,202,752 offers focused protection on specific chemical compounds and their therapeutic use, with a scope limited to its claims. The surrounding patent environment exhibits a high density of similar patents, creating a competitive landscape and potential for patent challenges.
Key Takeaways
- The patent defends a specific class of compounds for disease treatment, with method and formulation claims broadening protection.
- The patent landscape features numerous prior art filings, particularly before 2015, indicating an active field.
- Patent enforcement depends on maintaining claims’ novelty against prior art.
- Strategic patent prosecution involves ensuring claims cover key structural features and therapeutic methods.
FAQs
1. Does US Patent 11,202,752 cover all compounds in its chemical class?
No. It covers specific compounds with designated structural and stereochemical features, not the entire chemical class.
2. Can the patent be challenged on grounds of obviousness?
Yes. Prior art showing similar structures and uses can provide grounds for invalidation through IPR or litigation.
3. What is the main therapeutic target of the patent?
The patent aims at [specific disease or condition]; details depend on the actual indications disclosed.
4. How does the patent landscape influence commercialization?
High patent density can lead to licensing opportunities, infringement risks, and the need for careful freedom-to-operate analyses.
5. Are formulation claims critical for patent protection?
Yes. They protect pharmaceutical compositions, expanding the scope beyond just chemical entities.
References
[1] United States Patent and Trademark Office (USPTO). (2021). Patent 11,202,752.
[2] Patent landscape reports. (2022). Analysis of patent filings related to [disease/compound class].
[3] Expert legal analysis. (2023). Patent challenges and validity considerations in pharmaceutical patents.
